Pfizer reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Pfizer using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-04 | $0.63 | $0.46 | 37.0 % |
Q3 | 2024-10-29 | $1.06 | $0.62 | 71.0 % |
Q2 | 2024-07-30 | $0.60 | $0.46 | 30.4 % |
Q1 | 2024-05-01 | $0.82 | $0.52 | 57.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q4 | 2025-02-04 | $17.76B | $17.26B | 2.91 % |
Q3 | 2024-10-29 | $17.70B | $14.95B | 18.4 % |
Q2 | 2024-07-30 | $13.28B | $13.02B | 2.02 % |
Q1 | 2024-05-01 | $14.88B | $14.01B | 6.20 % |
Pfizer (PFE) is scheduled to report earnings on April 30, 2025. The last reported earnings were for reported on February 4, 2025 for Q4.
The Actual EPS was $0.63, which beat the estimate of $0.46.
The Actual Revenue was $17.8B, which beat the estimate of $17.3B.
Browse earnings estimates, EPS, and revenue on all stocks.